Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct Vancomycin for Surgical Infection Rates in Spinal Surgery
NCT02299882Unknown
- Sponsor
- Corewell Health
- Start
- Aug 2012
- Primary completion
- Aug 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vancomycin in surgical site infection (SSI) and Staphylococcus aureus infection (2 arms), sponsored by Corewell Health. Primary endpoint: Surgical wound infection rate, both deep and superficial infections at 12 weeks. Status: unknown.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT02299882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299882.